Cite
MLA Citation
Matthias Unseld et al.. “A higher ctDNA fraction decreases survival in regorafenib‐treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.” International journal of cancer, vol. 148, no. 6, 2021, pp. 1452–1461. http://access.bl.uk/ark:/81055/vdc_100119958734.0x00005f